Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CABTREO in Pediatric Participants Ages 9 to 11 Years With Acne Vulgaris
NCT07524946Phase 4Recruiting
- Sponsor
- Valeant Pharmaceuticals
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin phosphate + adapalene + benzoyl peroxide in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Apr 2026; status: recruiting.
02
Drugs
clindamycin phosphate + adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07524946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07524946.